Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma.
Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma.
复制标题
ADME 相关基因特征的开发和验证,用于头颈鳞状细胞癌的生存、治疗结果和免疫细胞浸润
DOI:
10.3389/fimmu.2022.905635
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Wen, Xin
中科院分区:
文献类型:
--
作者:
Tang, Xinran;Li, Rui;Wu, Dehua;Wang, Yikai;Zhao, Fang;Lv, Ruxue;Wen, Xin
关键词:
ADME genes are a set of genes which are involved in drug absorption, distribution, metabolism, and excretion (ADME). However, prognostic value and function of ADME genes in head and neck squamous cell carcinoma (HNSCC) remain largely unclear. In this study, we established an ADME-related prognostic model through the least absolute shrinkage and selection operator (LASSO) analysis in the Cancer Genome Atla (TCGA) training cohort and its robustness was validated by TCGA internal validation cohort and a Gene Expression Omnibus (GEO) external cohort. The 14-gene signature stratified patients into high- or low-risk groups. Patients with high-risk scores exhibited significantly poorer overall survival (OS) and disease-free survival (DFS) than those with low-risk scores. Receiver operating characteristic (ROC) curve analysis was used to confirm the signature’s predictive efficacy for OS and DFS. Furthermore, gene ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analyses showed that immune-related functions and pathways were enriched, such as lymphocyte activation, leukocyte cell-cell adhesion and T-helper cell differentiation. The Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) and other analyses revealed that immune cell (especially B cell and T cell) infiltration levels were significantly higher in the low-risk group. Moreover, patients with low-risk scores were significantly associated with immunotherapy and chemotherapy treatment benefit. In conclusion, we constructed a novel ADME-related prognostic and therapeutic biomarker associated with immune cell infiltration of HNSCC patients.
登录
查看更多内容
影响因子:
5.2
作者:
Hu DG;Mackenzie PI;Nair PC;McKinnon RA;Meech R
通讯作者:
Meech R
影响因子:
2.1
作者:
Dempsey, Jacqueline M.;Kidwell, Kelley M.;Hertz, Daniel L.
通讯作者:
Hertz, Daniel L.
DOI:
10.1124/jpet.118.255018
发表时间:
2019-03-01
影响因子:
3.5
作者:
Hu, Dong Gui;Marri, Shashikanth;Meech, Robyn
通讯作者:
Meech, Robyn
影响因子:
2.4
作者:
Han, Jiming;Wang, Lu;Zhang, Jing
通讯作者:
Zhang, Jing
影响因子:
3.5
作者:
Jittikoon, Jiraphun;Mahasirimongkol, Surakameth;Chantratita, Wasun
通讯作者:
Chantratita, Wasun